
Featured
FDA Approves Moderna's mFlusiva: First-Ever mRNA Flu Vaccine Cleared for Adults Over 50
The FDA has officially approved Moderna's mFlusiva, the first-ever mRNA-based seasonal flu vaccine, for adults aged 50 and older. The landmark decisio...
Read Full Story →